1,900% Stock Gains and Hate Mail: Welcome to Quantum Investing

1,900% Stock Gains and Hate Mail: Welcome to Quantum Investing

1,900% Stock Gains and Hate Mail: Welcome to Quantum Investing

The Trump administration has made quantum computing development a priority.
The Trump administration has made quantum computing development a priority.

Rigetti Computing Inc. and D-Wave Quantum Inc. make products that so far have few real world applications. They’re burning through cash and aren’t expected to generate significant amounts of revenue for years. Despite all that, investors can’t get enough of them.

The stocks have gained more than 1,900% over the past 12 months on bets the technology they’re developing will be the next big thing. The rally has placed them among the best performers in the stock market, dwarfing the returns of popular artificial intelligence plays like Palantir Technologies Inc. With market capitalizations that exceed $10 billion, the companies are more valuable than soup maker Campbell’s Co., even though they have less than 1% of the revenue.

Most Read from Bloomberg

Welcome to the world of quantum computing investing, which inhabits one of the most speculative and fiercely debated corners of the stock market. The companies are chasing a new kind of computer, exponentially more powerful than conventional machines.

For bulls, it’s only a matter of time until breakthroughs enable computing so powerful that the technology will transform the world by helping cure diseases and fighting climate change. Skeptics, meanwhile, see a momentum-fueled bubble based on hopes and dreams that’s destined to pop when the focus inevitably returns to fundamentals.

“If it works, it’s going to be huge and explosive,” said Troy Jensen, an analyst at Cantor Fitzgerald, who covers a handful of quantum computing stocks, including Rigetti and D-Wave. “If not, it could go to zero.”

The all-or-nothing nature of the trade has drawn comparisons to another group of stocks long synonymous with binary bets: biotechnology. In that sector, investors are willing to wait years on risky stock bets that drug development pipelines will eventually yield big payoffs.

The difference with quantum is that it’s mostly theoretical. Almost everyone agrees that the technology has vast potential, but no one can be certain if or when it will come to fruition.

Nvidia Corp. Chief Executive Officer Jensen Huang made a stir earlier this year when he suggested such outcomes could be decades away.

Captivating Potential

Still, there’s no shortage of interest in the field. The Trump administration has made quantum computing development a priority. Just this week, Fidelity International participated in a funding round for Quantinuum valuing the startup at $10 billion.

Leave a Comment

Your email address will not be published. Required fields are marked *